Tracks care and outcomes of people with HIV in France over time
Collects long-term health and treatment data from adults with HIV at 15 French clinics.
Key facts
- Who runs it
- DatAids
- Where
- Belfort, Besançon, Brest, BRIVE LA GAILLARDE, Clermont-Ferrand, Créteil, Faye-l'Abbesse, La Roche-sur-Yon, La Rochelle, Le Kremlin-Bicêtre, Limoges, Lyon, Marseille, Metz, Montpellier, Nancy, Nantes, Nice, Nîmes, Niort, Orléans, Paris, Quimper, Reims, Rennes, Rochefort, Rouen, Saint-Etienne, Strasbourg, Toulouse, Tourcoing, Troyes, Vannes, and Villeneuve-Saint-Georges, FranceSee the 37 sitesAlso in 2 other countries, 2 sites
- Trial code
- Registry title
- Quality of Care in French HIV Infected Patients
- Status
- Recruiting
- People taking part
- 30,000 people, planned
- Started
- Jan 2016
- Expected to end
- Jan 2030
- Type of study
- Observational
- Record updated
- 20 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults living with HIV-1 who receive care at HIV centers in France. Their health data is collected over time.
- Age
- 18 years and older
- Sex
- All sexes can join.
- Disease stage
- HIV-1 infection at any CD4 cell count.
- Earlier treatment
- It does not matter whether the person is on antiretroviral therapy or not.
Main reasons for not taking part
- Under 18 years of age
- No written informed consent
This trial only enrols participants living with HIV. The registry sentence this rests on: HIV-1 infected patients regardless of CD4 cell count and antiretroviral therapy status
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- HIV-1 infected patients regardless of CD4 cell count and antiretroviral therapy status
Who cannot take part
- Patients under 18 years of age
- Patients without written informed consent
Where in France
Also in 2 other countries, 2 sites
- Hôpital Nord Franche ComtéBelfort, FranceContact: Vincent GENDRINTaking people
- CHU Besancon - Hopital Jean MinjozBesançon, FranceContact: Catherine CHIROUZETaking people
- CHRU BrestBrest, FranceContact: Sylvain JAFFUELTaking people
- Centre hospitalier de BriveBRIVE LA GAILLARDE, FranceContact: Marion GAUDINTaking people
- CHU Clermont Ferrand - Hôpital Gabriel MontpiedClermont-Ferrand, FranceContact: Christine JACOMETTaking people
- CHICCréteil, FranceContact: Isabelle DELACROIXTaking people
- Faye-l'AbbesseHospital not named in the registryContact: Simon SUNDERTaking people
- CHD VendéeLa Roche-sur-Yon, FranceContact: Dominique MERRIENTaking people
- Centre Hospitalier de La RochelleLa Rochelle, FranceContact: Mariam RONCATOTaking people
- Hôpital Bicêtre - Assistance Publique des Hôpitaux de ParisLe Kremlin-Bicêtre, FranceContact: Antoine CHERETTaking people
- CHU LimogesLimoges, FranceContact: Jean-François FAUCHERTaking people
- Hôpital de la Croix Rousse, hospices civils de lyonLyon, FranceContact: Dulce ALFAIATETaking people
- Hôpital Sainte Marguerite - Assistance Publique des Hôpitaux de MarseilleMarseille, FranceContact: Sylvie BREGIGEON-RONOTTaking people
- IHU - Assistance Publique des Hôpitaux de MarseilleMarseille, FranceContact: Amélie MENARDTaking people
- Chr Metz-ThionvilleMetz, FranceContact: Céline ROBERTTaking people
- Hôpital Gui de ChauliacMontpellier, FranceContact: Alain MAKINSONTaking people
- CHU Nancy - Hôpital BraboisNancy, FranceContact: Benjamin LEFEVRETaking people
- CHU Nantes-Hotel DieuNantes, FranceContact: Clotilde ALLAVENATaking people
- CHU NiceNice, FranceContact: Pascal PUGLIESETaking people
- CH NîmesNîmes, FranceContact: Paul LOUBETTaking people
- Centre Hospitalier de NiortNiort, FranceContact: Simon SUNDERTaking people
- CHR OrléansOrléans, FranceContact: Laurent HOCQUELOUXTaking people
- Groupe Hospitalier Pitié Salpêtrière - Assistance Publique des Hôpitaux de ParisParis, FranceContact: Christine KATLAMATaking people
- Hôpital Bichat - Assistance Publique des Hôpitaux de ParisParis, FranceContact: Yazdan YAZDANPANAHTaking people
- Hôpital Necker-Pasteur - Assistance Publique des Hôpitaux de ParisParis, FranceContact: Claudine DUVIVIERTaking people
- Centre Hospitalier de CornouailleQuimper, FranceContact: Nolwenn HALLTaking people
- CHU Reims Hopital Robert DebreReims, FranceContact: Firouze BANISADRTaking people
- CHU Rennes - Hopital PontchaillouRennes, FranceContact: Cédric ARVIEUXTaking people
- CH RochefortRochefort, FranceContact: Mariam RONCATOTaking people
- CHU RouenRouen, FranceContact: Manuel ETIENNETaking people
- CHU ST ETIENNE - Hôpital NordSaint-Etienne, FranceContact: Amandine GAGNEUX-BRUNONTaking people
- CHU Strasbourg - Hôpital CivilStrasbourg, FranceContact: Axel URSENBACHTaking people
- CHU Toulouse - Hôpital PurpanToulouse, FranceContact: Pierre DELOBELTaking people
- CHU Tourcoing - Hôpital Guy ChatiliezTourcoing, FranceContact: Olivier ROBINEAUTaking people
- Ch TroyesTroyes, FranceContact: Simona PAVELTaking people
- CH Bretagne AtlantiqueVannes, FranceContact: Grégory CORVAISIERTaking people
- CHIVVilleneuve-Saint-Georges, FranceContact: Pauline CARAUX-PAZTaking people
About the trial
What the trial wants to find out
The objective of the Dataids cohort is to continue a long-term, prospective collection of clinical, laboratory and therapeutic data on a large cohort of HIV infected patients seeking care in 15 HIV centers in France in order :
Read full original descriptionShow less
1. to provide and develop a surveillance system to describe clinical practice and temporal changes in the clinical course of HIV and HIV-related co-infections and co-morbidities in France. 2. to assess the factors associated with the clinical, immunological and virological course of HIV infection and HIV-related co-infections and co-morbidities
The specific objectives are as follows
* To continue surveillance of HIV infection in France to describe temporal changes * To evaluate the efficacy of ART and factors associated with ART efficacy * To monitor the uptake and outcome of HCV therapy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Dataids Prospective Observational Cohort on Quality of Care of French HIV Infected Patients
- Plain-language title
- Tracks care and outcomes of people with HIV in France over timeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Publications
- Transient immediate systemic side effects following long-acting cabotegravir and rilpivirine injections in people with HIV: a 5-year cohort study.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2026
- Long‑Term Effectiveness and Safety of Doravirine‑Based Antiretroviral Regimens in Virologically Suppressed People with HIV: The French Dat'AIDS Cohort.Infectious diseases and therapy, 2026
- Switch to Bictegravir/Tenofovir Alafenamide/Emtrictabine or Dolutegravir + Tenofovir Disoproxil Fumarate/Emtrictabine in Virologically Suppressed People With HIV: Outcomes in Real-world Setting With and Without Tenofovir Resistance.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026
- Record updated
- 20 February 2026